Introduction
The global prevalence of type 2 diabetes (T2D) continues to rise, now affecting over 400 million individuals worldwide.1 Beyond its well-established complications such as cardiovascular disease and kidney failure, T2D has also been…

The global prevalence of type 2 diabetes (T2D) continues to rise, now affecting over 400 million individuals worldwide.1 Beyond its well-established complications such as cardiovascular disease and kidney failure, T2D has also been…

Adding to its diagnostic abilities, this study is the first to provide conclusive evidence of FFR-CT’s prognostic power, independent of other risk factors
Timothy Fairbairn
An artificial intelligence-based tool has been developed that analyses…

A syringe of the Fluarix flu vaccine is seen at International Community Health Services, Wednesday, Sept. 10, 2025, in Seattle. (AP Photo/Lindsey Wasson)